Breast Atypical Lobular Hyperplasia — Trials

Breast Atypical Lobular Hyperplasia — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04570956	Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk	terminated	Phase 2	65	Mayo ClinicOTHER	1	Sep 24, 2026	clinicaltrials
NCT06184750	Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial	recruiting	Phase 2	200	National Cancer Institute (NCI)NIH	1	Jul 27, 2026	clinicaltrials
NCT02928978	Ruxolitinib for Premalignant Breast Disease(TBCRC042)	completed	Phase 2	84	Julie NangiaOTHER	1	Apr 13, 2026	clinicaltrials
NCT07499999	Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

Data updated 4 days agoSource updated Sep 24, 2026source: clinicaltrials